IFNA2 and acquired polycythemia vera: Nevertheless, the effects of IFN-α demonstrated here may not be wholly specific to the V617F mutant, since stem cell derived erythrocytes containing JAK2 with exon 12 mutations (also causing constitutive JAK2 activation, as seen in PV) were also sensitive to IFN-α treatment (121).